Rameda Pharmaceutical Announces joining the Egyptian Exchange (EGX)

  • Home
  • -
  • News
  • -
  • Rameda Pharmaceutical Announces joining the Egyptian Exchange (EGX)
Rameda-Pharmaceutical-Announces-joining-the-Egypti

Rameda Pharmaceutical Announces joining the Egyptian Exchange (EGX)

Rameda Pharmaceutical, Egyptian Company, announced its plan to float 55.5% of its shares, Public offering & 2.9% private offering on the Egyptian Exchange (EGX).
 
Rameda hopes to raise 1.755 billion Egyptian pounds from its shares offer, which will be made in two tranches priced at 4.66 pounds per share, as mentioned in its prospectus published in the Egyptian newspapers.
 
One tranche, representing a 5% stake, will be sold to investors in a public offering, and the remainder 95% sold in a private offering. 
 
The company’s public offering would begin on Thursday 28th of November 2019 and will last for 5 working days.
 
Rameda was established by a group of Gulf investors in 1994, acting in the field of manufacturing and selling wide range of generic pharmaceutical products, exporting to six countries, according to its website.

 

Share

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn